Themis Medicare Limited (NSE:THEMISMED)

Market Cap	9.67B
Revenue (ttm)	3.80B
Net Income (ttm)	-90.71M
Shares Out	n/a
EPS (ttm)	-0.98
PE Ratio	n/a
Forward PE	n/a
Dividend	0.50 (0.48%)
Ex-Dividend Date	Jul 12, 2024

Volume	130,891
Average Volume	133,912
Open	107.11
Previous Close	107.49
Day's Range	103.07 - 111.00
52-Week Range	103.07 - 317.00
Beta	-0.13
RSI	22.64
Earnings Date	Aug 14, 2025

About Themis Medicare

Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. The company offers active pharmaceutical ingredients (APIs) and formulations for use in various therapeutic areas, including anti-tuberculosis, anti-malarials, cardiology, pain management, anti-infectives, haematinics, health and nutrition, anaesthesia, gynecology, and orthopedics. It also offers anti-inflammatory drugs and other drugs. The company was formerly known as Themis Chemicals and changed its name to Th...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1952
• Employees: 1,509
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: THEMISMED

Financial Performance

In 2024, Themis Medicare's revenue was 4.06 billion, an increase of 6.22% compared to the previous year's 3.82 billion. Earnings were 298.33 million, a decrease of -31.46%.